β2(CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 5, 1997, Pages 492-498

  Todd III, Robert F ^a   Petty, Howard R ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030871821     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90003-2     Document Type: Review

References (44)

1. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037-50.
2. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993;120:1031-43.
3. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ. Specificity of membrane complement receptor type III (CR3) for β-glucans. Complement 1987;4:61-74.
4. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type III (CD11b/CD18). J Immunol 1996;156:1235-46.
5. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
6. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 1994;4:506-17.
7. Arnaout MA, Todd III RF, Dana N, Melamed J, Schlossman S, Colten HR. Inhibition of phagocytosis of complement C3-or immunoglobulin G-coated particles and of iC3b binding by monoclonal antibodies to a monocyte-granulocyte membrane protein (Mo1). J Clin Invest 1983;72:171-9.
8. Wright SD, Rao PE, Van Voorhis WC, Craigmyle LS, Iida K, Talle MA, et al. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci USA 1983;80:5699-703.
9. Brown EJ, Bohnsack JF, Gresham HD. Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen. J Clin Invest 1988;81:365-75.
10. Anderson DC, Schmalstieg FC, Arnaout MA, Kohl S, Tosi MF, Dana N, et al. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface proteins (GP138): common relationship to diminished cell adherence. J Clin Invest 1984; 74:536-51.
11. Kohl S, Loo LS, Schmalstieg FS, Anderson DC. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibodydependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. J Immunol 1986;137:1688-94.
12. Graham IL, Gresham HD, Brown EJ. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. J Immunol 1989;142:2352-8.
13. Zhou M-J, Poo H, Todd RF, Petty HR. Surface-bound immune complexes trigger transmembrane proximity between complement receptor type III and the neutrophil's cortical microfiliments. J Immunol 1992;148:3550-3.
14. Zhou M-J, Todd III RF, van de Winkel CG, Petty HR. Co-capping of the leukoadhesion molecules complement receptor type III and lymphocyte function-associated antigen-1 with Fcγ receptor III in human neutrophils. Possible role of lectin-like interactions. J Immunol 1993;150:3030-41.
15. Poo H, Krauss JC, Mayo-Bond L, Todd III RF, Petty HR. Interaction of Fc-γ receptor type IIIB with complement receptor type III in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies. J Mol Biol 1995;247:597-603.
16. Galon J, Gauchat JF, Mazieres N, Spagnoli R, Storkus W, Lotz M, et al. Soluble Fey receptor type III (FcγRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol 1996;157:1184-92.
17. Stockl J, Majdic O, Pickl WF, Rosenkranz A, Prager E, Gschwantler E, et al. Granulocyte activation via a binding site near the C-terminal region of complement receptor type III α-chain (CD11b) potentially involved in integral membrane complex formation with glycosylphosphatidylinositol-anchored FcγRIIIB (CD16) molecules. J Immunol 1995;154: 5452-63.
18. 2, CD11b/ CD18) during neutrophil polarization. J Immunol 1996;156: 297-309.
19. Sehgal G, Zhang K, Todd III RF, Boxer LA, Petty HR. Lectinlike inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol 1993;150:4571-80.
20. Krauss JC, Poo H, Xue W, Mayo-Bond L, Todd III RF, Petty HR. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fcγ receptor IIIB and the complement receptor type III. J Immunol 1994;153:1769-77.
21. Dano K, Behrendt N, Brenner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994;8: 189-203.
22. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system for regulating cell migration and invasiveness. Bioessays 1993;15:105-11.
23. Xue W, Kindzelskii AL, Todd III RF, Petty HR. Physical association of complement receptor type III and urokinasetype plasminogen activator receptor in neutrophil membranes. J Immunol 1994;152:4630-40.
24. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, et al. Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995;181:1381-90.
25. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MD, et al. Regulation of integrin function by the urokinase receptor. Science 1996;273:1551-5.
26. Cao D, Mizukami IF, Garney-Wagner BA, Kindzelskii AK, Todd III RF, Boxer LA, et al. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type III and calcium. J Immunol 1995;154:1817-29.
27. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG. The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 1994;93:1380-7.
28. Gyetko MR, Sitrin RG, Fuller JA, Todd III RF, Petty HR, Standiford TJ. The function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukocyte Biol 1995;58: 533-8.
29. Sitrin RG, Todd III RF, Petty HR, Brock TG, Shollenberger SB, Albrecht E, et al. Urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996;97:1942-51.
30. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, et al. Mac-1(CD11b/CD18)and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996;88: 3185-94.
31. Kindzelskii AL, Eszes MM, Todd III RF, Petty HR. Complement type 4 receptor may restrain the urokinase receptor (uPAR) to the lamellipodium of migrating neutrophils. Blood 1995;86:426a.
32. Xue W, Mizukami M, Todd RF III, Petty HR. Urokinasetype plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res (in press).
33. Bianchi E, Ferrero E, Fazioli F, Mangili F, Wang J, Bender JR, et al. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J Clin Invest 1996; 98:1133-41.
34. Todd III RF, van Agthoven A, Schlossman S, Terhorst C. Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma 1982;1:329-37.
35. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;239:1431-3.
36. Zarewych DM, Kindzelskii AL, Todd III RF, Petty HR. LPS induces CD14 association with complement receptor type III, which is reversed by neutrophil adhesion. J Immunol 1996; 156:430-3.
37. Gadd J, Eher R, Majdic O, Knapp W. Signal transduction via FcyR and Mac-1 ct-chain in monocytes and polymorphonuclear leukocytes. Immunol 1994;81:611-7.
38. 2, CD11b/CD18) and FcγRIII cooperate in generation of the neutrophil respiratory burst: requirement for FcγRII and tyrosine phosphorylation. J Cell Biol 1994;125:1407-16.
39. Annenkov A, Ortlepp S, Hogg N. The β2 integrin Mac-1 but not p150,95 associates with Fc-yRIIa. Eur J Immunol 1996; 26:207-12.
40. Tuijnman WB, Capel TJA, van de Winkel JGJ. Human low-affinity IgG receptor Fc-yRIIa (CD32) introduced into mouse fibroblasts mediates phagocytosis of sensitized erythrocytes. Blood 1992;79:1651-6.
41. 2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosisdefective FcγRIIa (CD32) tail minus mutant. J Immunol 1996;157:5660-5.
42. Kindzelskii AL, Todd RF III, Boxer LA, Petty HR. CR3 promotes inter-receptor proximity on neutrophils. FASEB J 1994;8:A501.
43. Nykjaer A, Peterson CM, Moller B, Jensen PH, Moestrup SK, Holtet TL, et al. Purified α2 macroglobulin receptors/ LDL receptor-related protein binds urokinase plasminogen activator inhibitor type I complex: evidence that the α2 macroglobulin receptor mediates cellular degradation of urokinase-bound complexes. J Biol Chem 1992;267:14543-6.
44. Wright SD, Levin SM, Jong MTC, Chad Z, Kabbash LG. CR3 (CD11b/CD18) expresses one binding site for Arg-GlyAsp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989;169:175-83.